Skip to main content
logo
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.46
+0.05 (1.02%)
Aug 19, 2026, 11:59 AM EDT - Market open

TriSalus Life Sciences Revenue

TriSalus Life Sciences had revenue of $11.41M in the quarter ending June 30, 2026, with 1.73% growth. This brings the company's revenue in the last twelve months to $45.08M, up 25.25% year-over-year. In the year 2025, TriSalus Life Sciences had annual revenue of $45.15M with 53.41% growth.

Revenue (ttm)
$45.08M
Revenue Growth
+25.25%
P/S Ratio
7.47
Revenue / Employee
$441,931
Employees
102
Market Cap
335.89M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202545.15M15.72M53.41%
Dec 31, 202429.43M10.92M58.99%
Dec 31, 202318.51M6.11M49.31%
Dec 31, 202212.40M4.00M47.58%
Dec 31, 20218.40M2.97M54.60%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Orthofix Medical833.19M
Viemed Healthcare301.61M
Treace Medical Concepts205.31M
Pacific Biosciences of California159.27M
RxSight127.58M
AVITA Medical75.63M
Electromed71.75M
908 Devices60.84M
Revenue Rankings

TLSI News

More News